-
1321
Survival function analysis for LTFU according to Viral Load status and BMI status.
Published 2025Subjects: -
1322
-
1323
Annual incidence rate per 100 person-years trend for ART treatment outcomes.
Published 2025Subjects: -
1324
-
1325
-
1326
-
1327
-
1328
Isotype control overlays.
Published 2025“…Lung injury severity was estimated by determining lung damage scores, pulmonary oxidative, inflammatory factors and cell death. …”
-
1329
Original uncropped blot.
Published 2025“…Lung injury severity was estimated by determining lung damage scores, pulmonary oxidative, inflammatory factors and cell death. …”
-
1330
Raw Data.
Published 2025“…Lung injury severity was estimated by determining lung damage scores, pulmonary oxidative, inflammatory factors and cell death. …”
-
1331
PRISMA flow chart of the screening process.
Published 2025“…However, no significant difference between the two regimens was detected in estimated glomerular filtration rate (eGFR), alanine transferase (ALT) level, AST (aspartate transferase) level, Blood urea nitrogen (BUN) level, acute renal failure (ARF), and mortality rates.…”
-
1332
Forest plot of liver function tests.
Published 2025“…However, no significant difference between the two regimens was detected in estimated glomerular filtration rate (eGFR), alanine transferase (ALT) level, AST (aspartate transferase) level, Blood urea nitrogen (BUN) level, acute renal failure (ARF), and mortality rates.…”
-
1333
Subgroup analysis of BUN based on pump type.
Published 2025“…However, no significant difference between the two regimens was detected in estimated glomerular filtration rate (eGFR), alanine transferase (ALT) level, AST (aspartate transferase) level, Blood urea nitrogen (BUN) level, acute renal failure (ARF), and mortality rates.…”
-
1334
Subgroup analysis of ICU Stay based on pump type.
Published 2025“…However, no significant difference between the two regimens was detected in estimated glomerular filtration rate (eGFR), alanine transferase (ALT) level, AST (aspartate transferase) level, Blood urea nitrogen (BUN) level, acute renal failure (ARF), and mortality rates.…”
-
1335
Subgroup analysis of eGFR based on pump type.
Published 2025“…However, no significant difference between the two regimens was detected in estimated glomerular filtration rate (eGFR), alanine transferase (ALT) level, AST (aspartate transferase) level, Blood urea nitrogen (BUN) level, acute renal failure (ARF), and mortality rates.…”
-
1336
GRADE evidence profile.
Published 2025“…However, no significant difference between the two regimens was detected in estimated glomerular filtration rate (eGFR), alanine transferase (ALT) level, AST (aspartate transferase) level, Blood urea nitrogen (BUN) level, acute renal failure (ARF), and mortality rates.…”
-
1337
Characteristics of included studies.
Published 2025“…However, no significant difference between the two regimens was detected in estimated glomerular filtration rate (eGFR), alanine transferase (ALT) level, AST (aspartate transferase) level, Blood urea nitrogen (BUN) level, acute renal failure (ARF), and mortality rates.…”
-
1338
Sensitivity analysis for eGFR.
Published 2025“…However, no significant difference between the two regimens was detected in estimated glomerular filtration rate (eGFR), alanine transferase (ALT) level, AST (aspartate transferase) level, Blood urea nitrogen (BUN) level, acute renal failure (ARF), and mortality rates.…”
-
1339
Sensitivity analysis for BUN.
Published 2025“…However, no significant difference between the two regimens was detected in estimated glomerular filtration rate (eGFR), alanine transferase (ALT) level, AST (aspartate transferase) level, Blood urea nitrogen (BUN) level, acute renal failure (ARF), and mortality rates.…”
-
1340
Subgroup analysis of BUN based on surgery type.
Published 2025“…However, no significant difference between the two regimens was detected in estimated glomerular filtration rate (eGFR), alanine transferase (ALT) level, AST (aspartate transferase) level, Blood urea nitrogen (BUN) level, acute renal failure (ARF), and mortality rates.…”